Product Details

Artesunate Tablets BP 50 mg deliver a high-quality antimalarial therapy that meets British Pharmacopoeia (BP) standards. This formulation manages uncomplicated Plasmodium falciparum malaria by rapidly reducing parasite load in the bloodstream.

Each tablet contains:

• Artesunate, an artemisinin derivative that rapidly reduces parasite biomass by generating free radicals that damage the malaria parasite’s membrane structures.

Doctors and health programs commonly prescribe Artesunate as part of artemisinin-based combination therapy (ACT) regimens for uncomplicated falciparum malaria, valued for its rapid onset of parasite clearance. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant antimalarial therapy
• Treats uncomplicated Plasmodium falciparum malaria
• Delivers fast-acting artemisinin-based antimalarial action
• Accurate 50 mg dosage per tablet
• Maintains a high-purity, stable formulation
• Uses hygienic blister packaging for safe storage
• Suits hospital, clinical, and pharmacy use